MOS

The Mosaic Company

$23.19

-0.13%
Apr 28, 2026
Bobby Quantitative Model
The Mosaic Company is a global leader in the production and marketing of concentrated phosphate and potash crop nutrients, operating within the Agricultural Inputs industry. It is a vertically integrated producer with a distinct competitive identity as one of the world's largest players, owning key phosphate rock mines in the US and potash mines in Canada, complemented by a major fertilizer distribution network in Brazil. The current investor narrative is dominated by volatile commodity cycles and geopolitical supply shocks, with recent attention focused on the potential for margin expansion following the closure of the Strait of Hormuz, which has reportedly stranded a significant portion of global fertilizer supply, benefiting North American producers like Mosaic with localized input sources.

People also watch

Corteva

Corteva

CTVA

Analysis
CF Industries

CF Industries

CF

Analysis
The Scotts Miracle-Gro Company

The Scotts Miracle-Gro Company

SMG

Analysis
FMC Corporation

FMC Corporation

FMC

Analysis
Southern Copper Corporation

Southern Copper Corporation

SCCO

Analysis

MOS 12-Month Price Forecast

Historical Price
Current Price $23.19
Average Target $23.19
High Target $26.668499999999998
Low Target $19.7115

Wall Street consensus

Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $30.15 and implied upside of +30.0% versus the current price.

Average Target

$30.15

5 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

5

covering this stock

Price Range

$19 - $30

Analyst target range

Buy
1 (20%)
Hold
2 (40%)
Sell
2 (40%)

Analyst coverage is limited, with only 5 analysts providing estimates, indicating this is a stock with less institutional research focus which can lead to higher volatility. The consensus sentiment, inferred from recent institutional rating actions, leans neutral to cautious, with several firms like BofA Securities and Barclays downgrading to Neutral/Equal Weight from more bullish stances in early 2026, reflecting a shift in outlook. The target price range, derived from revenue and EPS estimates, shows high uncertainty; the average revenue estimate for the forward period is $11.9 billion, with a wide range from $10.3 billion to $13.6 billion, while the average EPS estimate is $2.04, ranging from $1.69 to $2.42—this broad dispersion signals low conviction and high uncertainty regarding the company's near-term financial performance, likely tied to volatile fertilizer commodity prices.

Drowning in data?

Find the real signal!

Bulls vs Bears: MOS Investment Factors

The evidence currently tilts bearish, driven by deteriorating fundamentals, severe negative momentum, and unsustainable cash burn. The bull case rests almost entirely on a deep-value valuation and a potential geopolitical catalyst reversing the margin and earnings decline. The single most important tension in the investment debate is whether the Strait of Hormuz supply shock and expected earnings recovery (forward P/E 9.85x) can overcome the powerful negative technical and fundamental trends (negative FCF, declining margins). If the earnings rebound fails to materialize, the stock's valuation support could vanish.

Bullish

  • Deep Discount Valuation: Mosaic trades at a forward P/E of 9.85x, a 30% discount to its trailing P/E of 14.14x, implying a significant earnings recovery is priced in. Its P/S ratio of 0.63x and P/B ratio of 0.63x are substantially below typical industry levels, suggesting the market has priced in severe cyclicality, leaving room for multiple expansion if fundamentals improve.
  • Geopolitical Supply Shock Catalyst: The reported closure of the Strait of Hormuz, which has stranded a third of global fertilizer supply, creates a direct margin opportunity for North American producers like Mosaic with localized input sources. This external shock could rapidly reverse the recent margin compression trend, where gross margin fell from 18.63% in Q1 2025 to 14.17% in Q4 2025.
  • Strong Balance Sheet & Liquidity: The company maintains a moderate debt-to-equity ratio of 0.44 and a healthy current ratio of 1.32, providing financial flexibility to navigate the commodity cycle downturn. This solid balance sheet position contrasts with the negative free cash flow, offering a buffer against operational headwinds.
  • Analyst Expectations for Earnings Recovery: The average analyst EPS estimate for the forward period is $2.04, representing a massive 278% increase from the most recent quarterly EPS of $0.55. This forward P/E of 9.85x, based on this estimate, suggests the stock is cheap if this earnings rebound materializes.

Bearish

  • Severe Negative Momentum & Technical Downtrend: The stock is down 17.04% over the past year and 19.95% over the past six months, severely underperforming the S&P 500 by 47.6% and 25.4% respectively. Currently trading at $24.00, just 5.8% above its 52-week low of $23.06, it shows persistent selling pressure and a lack of positive catalysts to reverse the trend.
  • Deteriorating Fundamentals & Negative Cash Flow: Q4 2025 revenue declined 7.55% YoY to $2.60B, and gross margin compressed sequentially from 15.98% to 14.17%. Critically, trailing twelve-month free cash flow is deeply negative at -$534.6 million, and the most recent quarterly operating cash flow was -$56 million, indicating the company is burning cash and cannot internally fund its operations.
  • High Uncertainty in Analyst Forecasts: Analyst EPS estimates for the forward period range widely from $1.69 to $2.42, and revenue estimates span from $10.3B to $13.6B. This broad dispersion signals low conviction and high uncertainty regarding near-term performance, reflecting the extreme volatility of fertilizer commodity prices that drive results.
  • Cyclical Industry with Volatile Earnings: The company's earnings are highly cyclical, as evidenced by quarterly net income swinging from $411.4M in Q3 2025 to $162.2M in Q4 2025. The trailing P/E of 14.14x is in the middle-to-lower end of its historical range, which has seen extremes from 5x to over 50x, indicating the market is not willing to pay a premium for this unpredictable earnings stream.

MOS Technical Analysis

The stock is in a pronounced downtrend, with a 1-year price change of -17.04% and a 6-month decline of -19.95%, significantly underperforming the S&P 500's 30.59% gain over the same period. Currently trading at $24.00, the price sits just 5.8% above its 52-week low of $23.06 and 37.2% below its 52-week high of $38.23, positioning it in the lower quartile of its annual range, which suggests deep value territory but also reflects persistent selling pressure and negative momentum. Recent short-term momentum shows further deterioration, with the stock down 8.36% over the past month and 16.64% over the past three months, a clear acceleration of the longer-term downtrend; this is underscored by a severe 1-month relative strength of -17.06% versus the S&P 500, indicating the stock is being aggressively sold off even as the broader market rallies. Key technical support is firmly established at the 52-week low of $23.06, while resistance lies at the recent March high near $31.36; a decisive break below $23.06 would signal a continuation of the bearish trend, whereas a sustained move above the $31 level could indicate a potential reversal. The stock's beta of 0.962 suggests its volatility is roughly in line with the market, but its recent price action has been markedly more negative, highlighting significant idiosyncratic or sector-specific risks.

Beta

0.96

0.96x market volatility

Max Drawdown

-38.7%

Largest decline past year

52-Week Range

$23-$38

Price range past year

Annual Return

-21.5%

Cumulative gain past year

PeriodMOS ReturnS&P 500
1m-7.2%+12.2%
3m-17.6%+2.3%
6m-16.3%+4.7%
1y-21.5%+29.2%
ytd-7.3%+4.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MOS Fundamental Analysis

Revenue growth has been inconsistent and recently negative, with Q4 2025 revenue of $2.60 billion representing a 7.55% year-over-year decline; the multi-quarter trend shows volatility, with revenue peaking at $3.45 billion in Q3 2025 before the recent drop, indicating sensitivity to fertilizer price cycles. The company remains profitable, posting Q4 2025 net income of $162.2 million, but profitability metrics have compressed, with the quarterly gross margin at 14.17%, down from 15.98% in the prior quarter and 18.63% in Q1 2025, reflecting margin pressure from lower selling prices or higher input costs. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.44, and a current ratio of 1.32 indicates sufficient short-term liquidity; however, cash flow generation has been weak, with trailing twelve-month free cash flow deeply negative at -$534.6 million, and the most recent quarterly operating cash flow was also negative at -$56 million, raising questions about the company's ability to internally fund operations and capital expenditures without external financing.

Quarterly Revenue

$2.6B

2025-12

Revenue YoY Growth

-0.07%

YoY Comparison

Gross Margin

+0.14%

Latest Quarter

Free Cash Flow

$-534600000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Mosaic Fertilizantes
Phosphates Segment
Potash Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MOS Overvalued?

Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 14.14x, while the forward P/E is notably lower at 9.85x, based on estimated EPS of $2.04; this significant gap implies the market expects a substantial earnings recovery in the coming year, pricing in improved profitability. Compared to sector averages, Mosaic trades at a deep discount based on its P/S ratio of 0.63x and P/B ratio of 0.63x; these multiples are substantially below typical industry levels for commodity producers, suggesting the market is assigning a low valuation to its sales and book value, likely due to cyclicality concerns and recent margin compression. Historically, the stock's current trailing P/E of 14.14x is below its own multi-year range observed in the data, which has seen peaks above 50x during low-earnings periods and lows near 5x during peak earnings cycles; trading near the middle-to-lower end of its historical band suggests the market is not pricing in extreme optimism, potentially leaving room for multiple expansion if the earnings cycle turns positive.

PE

14.1x

Latest Quarter

vs. Historical

High-End

5-Year PE Range -702x~58x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

4.8x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are pronounced, centered on cash flow sustainability and margin volatility. The company's trailing twelve-month free cash flow is deeply negative at -$534.6 million, and the most recent quarterly operating cash flow was -$56 million, indicating it cannot fund operations internally. Gross margin has compressed from 18.63% in Q1 2025 to 14.17% in Q4 2025, showing sensitivity to input costs and selling prices. While the debt-to-equity ratio of 0.44 is moderate, continued cash burn would force the company to draw on credit lines or raise capital, potentially diluting shareholders.

Market & Competitive Risks stem from its pure-play exposure to volatile fertilizer commodity cycles and its discounted valuation. Trading at a P/S of 0.63x and P/B of 0.63x, the stock is priced for distress, but this deep discount also reflects the market's expectation of continued poor performance. The beta of 0.962 suggests market-correlated volatility, but the stock's 1-month relative strength of -17.06% versus the S&P 500 shows significant idiosyncratic selling pressure. Recent analyst downgrades to Neutral by firms like BofA Securities and Barclays in early 2026 highlight a deteriorating institutional sentiment that could limit upside.

Worst-Case Scenario involves a failure of the geopolitical catalyst to materialize into sustained higher prices, coupled with a deeper-than-expected downturn in the agricultural cycle. This would lead to further margin compression, continued negative cash flow, and analyst EPS estimates trending toward the low end of the range ($1.69). The stock could re-test and break its 52-week low of $23.06, potentially falling toward the $20 level where it would trade at a forward P/E near 10x on significantly lowered earnings. From the current price of $24.00, a realistic downside in this adverse scenario is -15% to -20%, representing a loss of $3.50 to $4.80 per share.